This document summarizes the proceedings of the Scientific Workforce Diversity Seminar Series (SWDSS) virtual seminar, “How Does Diversity Affect Innovation in Pharma?,” which began the 2022–2023 series. The National Institutes of Health (NIH) Chief Officer for Scientific Workforce Diversity (COSWD) hosted the seminar on September 14, 2022. More than 300 people from NIH and other organizations attended. Marie A. Bernard, M.D., NIH COSWD, moderated a panel discussion on the evidence regarding the impact of diversity, equity, inclusion, and accessibility (DEIA) on innovation in the pharmaceutical industry. Four pharmaceutical leaders with scientific workforce diversity expertise shared perspectives and discussed current research, focusing on how inclusive, equitable workplace cultures can enhance creativity, team effectiveness, and outcomes.
